China Resources Pharmaceutical's (HKG:3320) unit KPC Pharmaceuticals obtained registration acceptance for a proposed bond issue from the National Association of Financial Market Institutional Investors.
The subsidiary can issue medium term bonds of up to 1 billion yuan in multiple tranches in China within two years of the notice, according to a Tuesday Hong Kong bourse filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.